NCT01803906
Tissue Sample Study for Mitochondrial Disorders
Enrolling by Invitation
Not specifiedAll AgesObservationalColumbia UniversityInvestigator-initiated
~6,900 participants
Updated 2026-01-07 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of patients with reduced respiratory chain enzyme levels
Measured over Up to 2 years
Conditions
NCT01803906
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Columbia University
New York, New Yorkno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Michio Hirano, MD · PRINCIPAL_INVESTIGATOR · Columbia University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients suspected of having a mitochondrial disorder
Patients who may carry a genetic mutation or be related to someone with a genetic mutation which may cause a mitochondrial disorder
Exclusion
Patients who are not suspected of having a mitochondrial disorder
What this trial measures
- Number of patients with reduced respiratory chain enzyme levelsUp to 2 years
Biochemical studies involving mitochondrial function. The levels will be compared to normal levels.